Terms: = Liver cancer AND KIT, C-Kit, 3815, ENSG00000157404, CD117, SCFR, P10721 AND Prognosis
295 results:
1. Mast Cells in the Microenvironment of Hepatocellular Carcinoma Confer Favorable prognosis: A Retrospective Study using QuPath Image Analysis Software.
Ali E; Červenková L; Pálek R; Ambrozkiewicz F; Pavlov S; Ye W; Hošek P; Daum O; Liška V; Hemminki K; Trailin A
J Vis Exp; 2024 Apr; (206):. PubMed ID: 38682951
[TBL] [Abstract] [Full Text] [Related]
2. CircSNX6 promotes proliferation, metastasis, and angiogenesis in hepatocellular carcinoma via miR-383-5p/VEGFA signaling pathway.
Tian Y; Han W; Lv K; Fu L; Zhou X
Sci Rep; 2024 Apr; 14(1):8243. PubMed ID: 38589413
[TBL] [Abstract] [Full Text] [Related]
3. Regorafenib and glioblastoma: a literature review of preclinical studies, molecular mechanisms and clinical effectiveness.
Mongiardi MP; Pallini R; D'Alessandris QG; Levi A; Falchetti ML
Expert Rev Mol Med; 2024 Apr; 26():e5. PubMed ID: 38563164
[TBL] [Abstract] [Full Text] [Related]
4. Sarcomatoid hepatocellular carcinoma: A case report and review of the literature.
Hu C; Zhao M; Wei Q; Chen Z; Zhao B
Medicine (Baltimore); 2024 Mar; 103(13):e37641. PubMed ID: 38552058
[TBL] [Abstract] [Full Text] [Related]
5. Fibroblast activation protein promotes progression of hepatocellular carcinoma via regulating the immunity.
Wang X; Niu R; Yang H; Lin Y; Hou H; Yang H
Cell Biol Int; 2024 May; 48(5):577-593. PubMed ID: 38501437
[TBL] [Abstract] [Full Text] [Related]
6. Clinical significance of small nuclear ribonucleoprotein U1 subunit 70 in patients with hepatocellular carcinoma.
Jiang D; Zhu XL; An Y; Li YR
PeerJ; 2024; 12():e16876. PubMed ID: 38500533
[TBL] [Abstract] [Full Text] [Related]
7. Routine evaluation of HBV-specific T cell reactivity in chronic hepatitis B using a broad-spectrum T-cell epitope peptide library and ELISpot assay.
Wu Y; Liu X; Mao Y; Ji R; Xia L; Zhou Z; Ding Y; Li P; Zhao Y; Peng M; Qiu J; Shen C
J Transl Med; 2024 Mar; 22(1):266. PubMed ID: 38468254
[TBL] [Abstract] [Full Text] [Related]
8. Inhibition of UBA52 induces autophagy via EMC6 to suppress hepatocellular carcinoma tumorigenesis and progression.
Tong L; Zheng X; Wang T; Gu W; Shen T; Yuan W; Wang S; Xing S; Liu X; Zhang C; Zhang C
J Cell Mol Med; 2024 Mar; 28(6):e18164. PubMed ID: 38445807
[TBL] [Abstract] [Full Text] [Related]
9. Extramedullary hematopoiesis in cancer.
Barisas DAG; Choi K
Exp Mol Med; 2024 Mar; 56(3):549-558. PubMed ID: 38443597
[TBL] [Abstract] [Full Text] [Related]
10. USP14 exhibits high expression levels in hepatocellular carcinoma and plays a crucial role in promoting the growth of liver cancer cells through the HK2/AKT/P62 axis.
Zhang N; Zhang H; Yang X; Xue Q; Wang Q; Chang R; Zhu L; Chen Z; Liu X
BMC Cancer; 2024 Feb; 24(1):237. PubMed ID: 38383348
[TBL] [Abstract] [Full Text] [Related]
11. Transcription factor RELA promotes hepatocellular carcinoma progression by promoting the transcription of m6A modulator METTL3.
Wu J; Wang W; Zheng Y; Deng W; Liu J
Pathol Res Pract; 2024 Mar; 255():155168. PubMed ID: 38367599
[TBL] [Abstract] [Full Text] [Related]
12. Downregulation of MTHFD2 Inhibits Proliferation and Enhances Chemosensitivity in Hepatocellular Carcinoma via PI3K/AKT Pathway.
Wang J; Yu Z; Jiang Y; Le T; Wu Y; Li Z; Zhang G; Wu F; Ma H
Front Biosci (Landmark Ed); 2024 Jan; 29(1):35. PubMed ID: 38287824
[TBL] [Abstract] [Full Text] [Related]
13. Establishment and Validation of Novel Prognostic Subtypes in Hepatocellular Carcinoma Based on Bile Acid Metabolism Gene Signatures Using Bulk and Single-Cell RNA-Seq Data.
Qu Y; Gong X; Zhao Z; Zhang Z; Zhang Q; Huang Y; Xie Q; Liu Y; Wei J; Du H
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38255993
[TBL] [Abstract] [Full Text] [Related]
14. The Prognostic and Therapeutic Roles of ARL-6 Gene in Hepatocellular Carcinoma.
Wang J; Che F; Zhao Y; Wei L; Chen D; Dai C; Zhang B; Zhou X; Yang B; Chen Z
Int J Med Sci; 2024; 21(2):207-218. PubMed ID: 38169538
[No Abstract] [Full Text] [Related]
15. Low expression of
Liang Q; Liu S; Yin F; Liu M; Wang L; Guo E; Lei L; Wu L; Yang Y; Zhang D; Zeng X
Biomark Med; 2023 Sep; 17(18):755-765. PubMed ID: 38095985
[No Abstract] [Full Text] [Related]
16. CHMP3 promotes the progression of hepatocellular carcinoma by inhibiting caspase‑1‑dependent pyroptosis.
Zheng Y; Yang S; Dai W; Wang J; Bi S; Zhang X; Zheng Z; Sun Y; Wu S; Kong J
Int J Oncol; 2024 Jan; 64(1):. PubMed ID: 38038147
[TBL] [Abstract] [Full Text] [Related]
17. The Pyroptosis-Related Signature Composed of GSDMC Predicts prognosis and Contributes to Growth and Metastasis of Hepatocellular Carcinoma.
Li M; Jiang Q; Liu X; Han L; Chen S; Xue R
Front Biosci (Landmark Ed); 2023 Oct; 28(10):235. PubMed ID: 37919059
[TBL] [Abstract] [Full Text] [Related]
18. Curcumin Induces Apoptosis by Suppressing XRCC4 Expression in Hepatocellular Carcinoma.
Wang S; Wu W; Liu Y; Xing E; Jiao J; Li L; Li J; Wang D
Nutr Cancer; 2023; 75(10):1958-1967. PubMed ID: 37899756
[TBL] [Abstract] [Full Text] [Related]
19. Tex10 interacts with STAT3 to regulate hepatocellular carcinoma growth and metastasis.
Xiang X; Kuang W; Yu C; Li Y; Su Q; Tian Y; Li J
Mol Carcinog; 2023 Dec; 62(12):1974-1989. PubMed ID: 37792308
[TBL] [Abstract] [Full Text] [Related]
20. HSDL2 knockdown promotes the progression of cholangiocarcinoma by inhibiting ferroptosis through the P53/SLC7A11 axis.
Ma S; Ma Y; Qi F; Lei J; Chen F; Sun W; Wang D; Zhou S; Liu Z; Lu Z; Zhang D
World J Surg Oncol; 2023 Sep; 21(1):293. PubMed ID: 37718459
[TBL] [Abstract] [Full Text] [Related]
[Next]
